Force Family Office Fireside Chat: Expert Panel Discusses DiscGenics’ Potential Cure for Degenerative Disc Disease

We are proud to share our recent feature in a Force Family Office Fireside Chat, where our groundbreaking non-invasive cell therapy, IDCT, was discussed as a potential breakthrough in the treatment of degenerative disc disease. This engaging Fireside Chat, hosted by Force Family Office, highlights the promising impact of IDCT in revolutionizing care for chronic back pain.

Featured Panelists:

  1. Dr. Matthew F. Gornet: A Board Certified Spine Surgeon and national leader in the development of dynamic stabilization, disc replacement, and “non-fusion” technology.

  2. Ryan Zimmerman: Managing Director and Medical Technology Analyst at BTIG and former Director of Surgery at Advocate Christ Medical Center in Chicago.

  3. Francine W. Schranck: President, SPIRITT, a patient-centric specialty research organization dedicated to excellence in all aspects of clinical outcomes and study management.

  4. Flagg Flanagan: CEO & Chairman of DiscGenics, an entrepreneur, executive, and advisor with more than 30 years of experience in the surgical device and biopharmaceutical fields.

Webinar Highlights:

  • Learn about the cutting-edge injectable Discogenic cell therapy (IDCT) and its potential to transform the treatment of degenerative disc disease

  • Discover the results of clinical trials showcasing reduced back pain, improved quality of life, and increased disc volume

Highlights from Ryan Zimmerman

Discover the exciting opportunities that lie ahead in the treatment of back pain in this highlight video featuring Ryan Zimmerman, BTIG Managing Director. In this insightful talk, Zimmerman discusses the significant treatment gap for back pain, the crucial elements analysts seek in effective treatments, and how DiscGenics is stepping up to fill these needs. He elaborates on the importance of a Biologics License Application (BLA) from an investment perspective, the role of IP protection, and how DiscGenics' Injectable Cell Therapy presents an uncorrelated opportunity. Join us in understanding DiscGenics' groundbreaking approach and the transformative potential it holds.

Highlights from Dr. Matthew Gornett

Join Spine Surgeon Dr. Matthew F. Gornett as he highlights the impressive clinical results and the remarkable potential of DiscGenics' Injectable Disc Cell Therapy in this video excerpt from our recent webinar. Understand what sets DiscGenics apart and explore the groundbreaking strides we are making in the world of spine treatment.